Skip to main content

Savant Capital, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1482880 ROCKFORD, IL

Position in GILD

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$4,207,859
+$883,569 QoQ
Shares Held
30,192
+11.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 55.4054054054054.ToString("F0")% Shared 14.815182829888712.ToString("F0")% None 29.77941176470588.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Savant Capital, LLC holds $182,516,970 across 15 Drug Manufacturers - General names. GILD ranks #8 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
30,192 $4,207,859

All Filings in GILD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,207,859 30,192
2025-12-31 $3,324,290 27,084
2025-09-30 $2,829,945 25,495
2025-06-30 $2,731,282 24,635
2025-03-31 $2,396,301 21,386
2024-12-31 $2,579,062 27,921
2024-09-30 $2,294,113 27,363
2024-06-30 $1,597,652 23,286
2024-03-31 $1,833,667 25,033
2023-12-31 $2,086,007 25,750
2023-09-30 $1,995,277 26,625
2023-06-30 $2,063,626 26,776
2023-03-31 $2,192,067 26,420
2022-12-31 $2,164,879 25,217
2022-09-30 $551,631 8,942
2022-06-30 $566,674 9,168
2022-03-31 $493,851 8,307
2021-12-31 $568,245 7,826
2021-09-30 $402,894 5,768
2021-06-30 $419,701 6,095
2021-03-31 $399,865 6,187
2020-12-31 $355,036 6,094
2020-09-30 $428,744 6,785
2020-06-30 $550,736 7,158
2020-03-31 $511,134 6,837